• linkedin
  • Increase Font
  • Sharebar

    New Products: FDA approves treatment for complicated UTI

     

    Vabomere

    FDA approves treatment for complicated UTI

    The FDA has approved the combination of meropenem and vaborbactam (VABOMERE) for injection for the treatment of adult patients with complicated urinary tract infections (cUTI), including pyelonephritis, caused by designated susceptible Enterobacteriaceae—Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae species complex. The combination therapy addresses gram-negative bacteria that produce beta-lactamase enzymes that have spread in the United States and Europe, particularly the Klebsiella pneumoniae carbapenemase enzyme. It is expected that the drug will be available in the fourth quarter of 2017, according to the Medicines Company.

    For more information, go www.themedicinescompany.com/.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll